NOVEN TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE |
BackMiami, FL, September 11, 2008 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced that Peter Brandt, Noven’s President & Chief Executive Officer, is scheduled to present an update on Noven’s business and prospects at the UBS Global Life Sciences Conference in New York City on Monday, September 22nd at 12:30 p.m. ET. The presentation will be webcast live at www.noven.com, and a rebroadcast will be available thereafter for at least two weeks at the same site.
Noven Pharmaceuticals,
Inc. is a specialty pharmaceutical company engaged in the research,
development, manufacture, marketing and sale of prescription pharmaceutical
products. Noven’s business and operations are focused in three
principal areas – transdermal drug delivery, the Novogyne joint
venture, and Noven Therapeutics, Noven’s specialty pharmaceutical
unit. For more information about Noven Pharmaceuticals, visit www.noven.com.
Contact:
|
Copyright © 2008 Noven Pharmaceuticals, Inc. All rights reserved.